The company is not selling any securities under this filing and will not receive any of the proceeds from the sale of shares of its common stock by the selling stockholders.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD:
- Lucid Diagnostics Insights: Performance and Outlook Update
- PAVmed Provides Business Update and First Quarter 2024 Financial Results
- Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
- Lucid Diagnostics reports Q1 non-GAAP EPS (21c), consensus (27c)
- Lucid SOS esophageal cell collection device subject to Class II FDA recall
Questions or Comments about the article? Write to editor@tipranks.com